These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Endothelin receptors: binding and phosphoinositide breakdown in human myometrium. Breuiller-Fouché M; Héluy V; Fournier T; Ferré F J Pharmacol Exp Ther; 1994 Sep; 270(3):973-8. PubMed ID: 7932209 [TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Nishikibe M Br J Pharmacol; 1994 Oct; 113(2):336-8. PubMed ID: 7834180 [TBL] [Abstract][Full Text] [Related]
24. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Tanaka T; Tsukuda E; Nozawa M; Nonaka H; Ohno T; Kase H; Yamada K; Matsuda Y Mol Pharmacol; 1994 Apr; 45(4):724-30. PubMed ID: 8183252 [TBL] [Abstract][Full Text] [Related]
25. Endothelin-induced nociception in mice: mediation by ETA and ETB receptors. Raffa RB; Schupsky JJ; Jacoby HI J Pharmacol Exp Ther; 1996 Feb; 276(2):647-51. PubMed ID: 8632332 [TBL] [Abstract][Full Text] [Related]
26. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Maguire JJ; Kuc RE; O'Reilly G; Davenport AP Br J Pharmacol; 1994 Sep; 113(1):49-54. PubMed ID: 7812631 [TBL] [Abstract][Full Text] [Related]
27. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit. Maurice MC; Gratton JP; D'Orléans-Juste P Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126 [TBL] [Abstract][Full Text] [Related]
28. Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Bax WA; Bruinvels AT; van Suylen RJ; Saxena PR; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):403-10. PubMed ID: 8277976 [TBL] [Abstract][Full Text] [Related]
29. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Nambi P; Wu HL; Pullen M; Aiyar N; Bryan H; Elliott J Mol Pharmacol; 1992 Aug; 42(2):336-9. PubMed ID: 1325032 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Awane-Igata Y; Ikeda S; Watanabe T Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758 [TBL] [Abstract][Full Text] [Related]
31. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity. Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302 [TBL] [Abstract][Full Text] [Related]
32. Endothelin ETA and ETB receptors facilitating parasympathetic neurotransmission in the rabbit trachea. Yoneyama T; Hori M; Tanaka T; Matsuda Y; Karaki H J Pharmacol Exp Ther; 1995 Dec; 275(3):1084-9. PubMed ID: 8531067 [TBL] [Abstract][Full Text] [Related]
33. [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. Ihara M; Yamanaka R; Ohwaki K; Ozaki S; Fukami T; Ishikawa K; Towers P; Yano M Eur J Pharmacol; 1995 Feb; 274(1-3):1-6. PubMed ID: 7768260 [TBL] [Abstract][Full Text] [Related]
34. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Warner TD; Allcock GH; Vane JR Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643 [TBL] [Abstract][Full Text] [Related]
35. A novel ligand, [125I]BQ-3020, reveals the localization of endothelin ETB receptors. Kobayashi M; Ihara M; Sato N; Saeki T; Ozaki S; Ikemoto F; Yano M Eur J Pharmacol; 1993 Apr; 235(1):95-100. PubMed ID: 8519285 [TBL] [Abstract][Full Text] [Related]
36. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels. Gardner A; Westfall TC; Macarthur H J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374 [TBL] [Abstract][Full Text] [Related]
37. Role of positions 9 and 10 in the endothelin molecule for biological activity and discrimination of receptor subtypes. Miasiro N; De Castiglione R; Paiva AC Eur J Pharmacol; 1995 May; 278(2):103-9. PubMed ID: 7671994 [TBL] [Abstract][Full Text] [Related]
38. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Mizuguchi T; Nishiyama M; Moroi K; Tanaka H; Saito T; Masuda Y; Masaki T; de Wit D; Yanagisawa M; Kimura S Br J Pharmacol; 1997 Apr; 120(8):1427-30. PubMed ID: 9113361 [TBL] [Abstract][Full Text] [Related]
39. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus. Hay DW; Luttmann MA; Beck G; Ohlstein EH Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345 [TBL] [Abstract][Full Text] [Related]
40. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors. Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]